The study found no significant OS or PFS improvement with auto-HCT plus Rituxan versus Rituxan alone in MCL patients in first complete remission with undetectable MRD. Three-year OS rates were 82.1% ...

Hospitals are seeing success treating multiple myeloma with advanced therapies. Second autologous stem cell transplants, even ...

Umbilical cord blood transplantation has transformed the treatment options for patients with blood cancers and other ...

As treatment options for acute myeloid leukemia (AML) evolve, new therapies could change the patient experience around ...

Homi Bhabha Cancer Hospital performs India's first tandem stem cell transplant on a three-year-old girl with rare brain cancer.

It is the first evidence that MCL patients in complete remission, with undetectable minimal residual disease (MRD), may be able to rely on highly effective standard treatments and avoid the rigors of ...

A new study led by Fred Hutch Cancer Center looked at zip codes to assess socioeconomic status and access to bone marrow transplants SAN DIEGO, Calif. — Dec. 8, 2024 — Patients with acute myeloid ...

SAN DIEGO -- Patients with mantle cell lymphoma (MCL) and undetectable minimal residual disease (uMRD) after induction therapy did not live longer if they underwent hematopoietic cell transplantation ...

Please provide your email address to receive an email when new articles are posted on . Research has shown that autologous hematopoietic stem cell transplantation is an effective treatment for MS. At ...

Autologous stem cell transplant for patients with diffuse systemic sclerosis (SSc), without selecting for a particular hematopoietic cell type, performed about as well in a new single-arm trial as was ...

Visakhapatnam: In a major medical breakthrough, Homi Bhabha Cancer Hospital and Research Centre (HBCHRC) has successfully performed a rare tandem auto.